Thomas Grünewald

49PUBLICATIONS
335CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursDisease surveillanceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Feb 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors.

Iris H Nelen, Soetkin Leys, Sarah-Lee Bekaert

|Jan 03, 2026
Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma.

Veveeyan Suresh, Christoph Hafemeister, Andri Konstantinou

|Oct 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.

Sandra Küchler, Silke Brilloff, Silvia Schäfer

|Sep 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.

Antonio Juan Ribelles, Arthur Felix, Nuria Benavent

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Aug 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

Sonja Herter, Marta Emperador, Kyriaki Smyrilli

Pageof 9

Frequent Collaborators

8 joint publications

Florencia Cidre-Aranaz

8 joint publications

Maximilian M L Knott

7 joint publications

James F Amatruda

5 joint publications

Didier Surdez